Mikra Cellular Sciences Raises $8.5M in Funding

mikra

Funding of $8.5M was raised by Mikra Cellular Sciences, a Toronto-based company that specializes in biological sciences and consumer wellbeing.

The investment was made by Lifeist Wellness, Inc., the parent company.

The company intends use the funds:

  • to market its first product, CELLF™, engineered to increase cellular performance, as well as
  • to continue product development.

Mikra, headed by Faraaz Jamal as CEO, is a biosciences and consumer wellness company that offers CELLF, a unique cellular therapeutic compound, to boost energy and mental focus at a cellular level. CELLF is a compound that counteracts the effects of oxidative stresses and damages to the internal cellular systems. It also helps to restore homeostasis. CELLF, which is only made in small quantities and in an oxygen-deprived atmosphere, works at the cellular level to fight systemic fatigue and inflammation. CELLF uses a proprietary delivery system that uses a transferrin- glyco-protein. This ensures that bioactive compounds are delivered to their best sites of absorption and directly into cells.

The company currently has a patent pending on CELLF’s formulation and mechanism of action and is currently conducting genomic pre-clinical trials to demonstrate the efficacy of the product at a genetic level with InVivo Biosystems. As the scientific results from trials reveal more information, Mikra will continue to improve CELLF. An advisory group of medical scientists and physicians will consult on the product.

 

Get latest news from African Startup ecosystem

Latest stories

You might also like...